President Joe Biden’s Inflation Reduction Act gave the government sweeping new power to set the price Medicare will pay for ...

The Biden administration unveiled a new framework outlining the factors federal agencies should consider in determining ...

The Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies that it might use its authority to cancel patent protections if a medication ...

Only one company has responded to an FTC demand for several drugmakers to delist dozens of patents that were improperly or ...

To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.

Under a plan announced Thursday, the government would consider overriding the patent for high-priced drugs developed with the help of taxpayer money.

Medicare’s drug price negotiation program violates the Constitution and must be struck down, Novartis Pharmaceuticals said in ...

The first 10 drugs included in the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA) were ...

We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price negotiations (aka price controls) to the recent proposals directed at ...

Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly ...

The pharmaceutical industry suffered a huge legislative defeat last year when Congress and President Joe Biden enacted a law ...